Table 1 Demographic and clinical characteristics of neurological progression groups a
From: Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp41 and iNOS
Data | Nondemented (n = 8) | Non-Progressors (n = 3) | Moderate Progressors (n = 4) | Rapid Progressors (n = 4) |
|---|---|---|---|---|
Age (years) | 45.00 ± 7.04 | 40.75 ± 5.50 | 37.25 ± 0.99 | 46.25 ± 3.84 |
Survival (months) | n/a | 16.80 ± 28.27 | 11.75 ± 4.15 | 4.00 ± 0.94 |
CD4 count | 76.67 ± 54.89 | 50.25 ± 55.17 | 77.00 ± 47.38 | 23.00 ± 13.47 |
PMI (hr) | 14.38 ± 1.79 | 7.75 ± 1.5 | 20.5 ± 6.37 | 54.75 ± 52.12 |
MSK | 0.00 ± 0.00 | 2.00 ± 0.00 | 2.25 ± 0.29 | 3.00 ± 0.47 |